Safety analysis of raltegravir/truvada regimen in HIV/HCV co-infected patients without switchback after HCV treatment

INTRODUCTION: Due to drug-drug interactions of HIV- and HCV-specific antivirals when initiating an HCV-therapy, the antiretroviral therapy (ART) often has to be changed. The spectrum of applicable antiretrovirals is small, therefore many patients were switched to raltegravir/truvada (RAL/TVD) in our...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehret, Robert, Walter, Hauke, Ingiliz, Patrick, Baumgarten, Axel, Obermeier, Martin, Krznaric, Ivanka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P112
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224928/
https://www.ncbi.nlm.nih.gov/pubmed/25394148
http://dx.doi.org/10.7448/IAS.17.4.19644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224928/
https://www.ncbi.nlm.nih.gov/pubmed/25394148
http://dx.doi.org/10.7448/IAS.17.4.19644

Ejemplares similares